In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Sirolimus, Rapamune,Rapamycin Drug Master File in Korea (Sirolimus, Rapamune,Rapamycin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Sirolimus, Rapamune,Rapamycin. The MFDS reviews the Sirolimus, Rapamune,Rapamycin KDMF as part of the drug registration process and uses the information provided in the Sirolimus, Rapamune,Rapamycin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Sirolimus, Rapamune,Rapamycin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Sirolimus, Rapamune,Rapamycin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Sirolimus, Rapamune,Rapamycin suppliers with KDMF on PharmaCompass.